Page last updated: 2024-11-04

terazosin and Acute Kidney Failure

terazosin has been researched along with Acute Kidney Failure in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Research Excerpts

ExcerptRelevanceReference
"Mice treated with terazosin had a significant decrease in serum creatinine, urinary Kim-1 levels, HIF-1α, apoptosis, and downstream Adrab1 genes including Ece1, Edn1, pMAPK14 with increased cell proliferation."1.62Identification of novel therapeutic targets for contrast induced acute kidney injury (CI-AKI): alpha blockers as a therapeutic strategy for CI-AKI. ( Cai, C; Kilari, S; Misra, S; Sharma, A; Simeon, M; Singh, A; van Wijnen, AJ; Zhao, C, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kilari, S1
Sharma, A1
Zhao, C1
Singh, A1
Cai, C1
Simeon, M1
van Wijnen, AJ1
Misra, S1

Other Studies

1 other study available for terazosin and Acute Kidney Failure

ArticleYear
Identification of novel therapeutic targets for contrast induced acute kidney injury (CI-AKI): alpha blockers as a therapeutic strategy for CI-AKI.
    Translational research : the journal of laboratory and clinical medicine, 2021, Volume: 235

    Topics: Acute Kidney Injury; Adrenergic alpha-1 Receptor Antagonists; Animals; Apoptosis; Cell Proliferation

2021